A systematic molecular and pharmacologic evaluation of AKT inhibitors reveals new insight into their biological activity.

MLA

Kostaras, Eleftherios, et al. “A Systematic Molecular and Pharmacologic Evaluation of AKT Inhibitors Reveals New Insight into Their Biological Activity.” British Journal of Cancer, vol. 123, no. 4, Aug. 2020, pp. 542–55. EBSCOhost, https://doi.org/10.1038/s41416-020-0889-4.

APA

Kostaras, E., Kaserer, T., Lazaro, G., Heuss, S. F., Hussain, A., Casado, P., Hayes, A., Yandim, C., Palaskas, N., Yu, Y., Schwartz, B., Raynaud, F., Chung, Y.-L., Cutillas, P. R., & Vivanco, I. (2020). A systematic molecular and pharmacologic evaluation of AKT inhibitors reveals new insight into their biological activity. British Journal of Cancer, 123(4), 542–555. https://doi.org/10.1038/s41416-020-0889-4

Chicago

Kostaras, Eleftherios, Teresa Kaserer, Glorianne Lazaro, Sara Farrah Heuss, Aasia Hussain, Pedro Casado, Angela Hayes, et al. 2020. “A Systematic Molecular and Pharmacologic Evaluation of AKT Inhibitors Reveals New Insight into Their Biological Activity.” British Journal of Cancer 123 (4): 542–55. doi:10.1038/s41416-020-0889-4.